Dannielle Appelhans - Feb 24, 2023 Form 4 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role: CEO and President
Signature: /s/ Dannielle Appelhans
Stock symbol: RUBY
Transactions as of: Feb 24, 2023
Transactions value $: -$1,323
Form type: 4
Date filed: 2/27/2023, 05:08 PM
Previous filing: Feb 1, 2023
Next filing: Jun 12, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RUBY	Common Stock	Sale	-$1.32K	-10.4K	-100%	$0.13^*	0	Feb 24, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.